A. Hart

发表

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

Yudong D. He, M. Marton, S. Friend, 2002 .

Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.

A. Hart, F. Ong, L. Moonen, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Gene expression profiling predicts clinical outcome of breast cancer

Yudong D. He, M. Marton, S. Friend, 2002, Nature.

Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.

A. Hart, R. Michalides, N. V. van Veelen, 1995, Cancer research.

Validation of 70-gene prognosis signature in node-negative breast cancer

A. Hart, J. Peterse, A. Glas, 2009, Breast Cancer Research and Treatment.

Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial

A. Hart, J. Zee, D. González, 2000, The Lancet.

Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling.

Joos V Lebesque, Mischa S Hoogeman, A. Hart, 2006, International journal of radiation oncology, biology, physics.

Prognostic factors of neck node metastasis.

A. Hart, H. Bartelink, G. Snow, 1982, Clinical otolaryngology and allied sciences.

Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes

A. Hart, F. Kate, F. Lammes, 1997, Cancer.

Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.

Monique W M Jaspers, A. Hart, C. Koning, 2007, JAMA.

The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer.

A. Hart, E. Rutgers, R. Kaas, 2005, Breast.

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer

A. Hart, J. Peterse, E. Rutgers, 2003, British Journal of Cancer.

Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy.

A. Hart, F. Zoetmulder, S. van Ruth, 2003, Anticancer research.

Postoperative radiotherapy for rectal and rectosigmoid cancer: the impact of total dose on local control.

A. Hart, J. Lebesque, B. Aleman, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic Significance of CEA in Colorectal Cancer: A Statistical Study. Clinical evaluation of carcino-embryonic antigen, V

A. Hart, J. Persijn, 1981, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients

A. Hart, S. Rodenhuis, L. J. Veer, 2003, British Journal of Cancer.

Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors

A. Hart, F. Hilgers, A. Balm, 1999, Cancer.

Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors

A. Hart, F. Hilgers, A. Balm, 1999, Cancer.

The H-reflex of the flexor carpi radialis muscle; a study in controls and radiation-induced brachial plexus lesions.

A. Hart, B. W. Ongerboer de Visser, R. Schimsheimer, 1984, Journal of neurology, neurosurgery, and psychiatry.

Prognostic index for patients with parotid carcinoma

A. Hart, A. Balm, C. Meeuwis, 2003, Cancer.

Limb-sparing therapy of extremity soft tissue sarcomas: treatment outcome and long-term functional results.

A. Hart, E. Rutgers, R. Keus, 1994, European journal of cancer.

Management of Cervical Metastases in Supraglottic Cancer

A. Hart, F. Hilgers, A. Balm, 1996, The Annals of otology, rhinology, and laryngology.

Pulmonary Squamous Cell Carcinoma following Head and Neck Squamous Cell Carcinoma: Metastasis or Second Primary?

L. V. van't Veer, A. Hart, D. de Jong, 2005, Clinical Cancer Research.

Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer.

A. Hart, A. Hart, P. Demant, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial

A. Hart, J. Zee, D. González, 2000, The Lancet.

Tamoxifen, serum lipoproteins and cardiovascular risk.

A. Hart, P. Bruning, J. van Loon, 1988, British Journal of Cancer.

Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer.

A. Hart, P. Bruning, A. E. van den Ende, 1990, British Journal of Cancer.

Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.

Zanten, A. Hart, A. Twijnstra, 1991, Journal of neurology, neurosurgery, and psychiatry.

A new independent validation of the 70-gene signature in node-negative breast cancer

A. Hart, L. J. Veer, S. Linn, 2006 .

Insulin‐like growth‐factor‐binding protein 3 is decreased in early‐stage operable pre‐menopausal breast cancer

T. C. Linders, A. Hart, P. V. van Noord, 1995, International journal of cancer.

High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.

A. Hart, H. Bartelink, D. de Jong, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pulmonary resection for metastases of colorectal origin.

A. Hart, A. V. van Geel, H. V. van Halteren, 1995, Chest.

Brain metastases in breast cancer; natural history, prognostic factors and outcome

A. Hart, W. Boogerd, G. Baris, 1993, Journal of Neuro-Oncology.

Treatment and outcome of brain metastasis as first site of distant metastasis from breast cancer

A. Hart, W. Boogerd, I. Tjahja, 1997, Journal of Neuro-Oncology.

A clinicopathological study of 30 melanomas of the vulva

A. Hart, G. B. Rivière, E. W. Tasseron, 1992 .

The prognostic significance of a previous malignancy in operable non-small cell lung cancer.

A. Hart, E. Rutgers, P. Baas, 2001, Lung cancer.

Most Lung and Colon Cancer Susceptibility Genes Are Pair-Wise Linked in Mice, Humans and Rats

A. Hart, A. Hutson, T. van Wezel, 2011, PloS one.

Cerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases.

A. Hart, A. Twijnstra, B. W. Ongerboer de Visser, 1986, Clinica chimica acta; international journal of clinical chemistry.

Cerebrospinal fluid beta 2-microglobulin: a study in controls and patients with metastatic and non-metastatic neurological diseases.

A. Hart, A. Twijnstra, B. W. Ongerboer de Visser, 1986, European journal of cancer & clinical oncology.

Cerebrospinal fluid beta-glucuronidase activities in patients with central nervous system metastases.

A. Hart, A. Twijnstra, B. W. Ongerboer de Visser, 1985, Clinica chimica acta; international journal of clinical chemistry.

Patients' and doctors' delay in the diagnosis and treatment of cutaneous melanoma.

A. Hart, P. Rümke, F. Rampen, 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Kras-2 alleles, mutations, and lung tumor susceptibility in the mouse--an evaluation.

A. Hart, R. Ophoff, P. Demant, 1994, Oncogene.

Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept.

A. Hart, D. de Jong, D. Jong, 1996, Gut.

Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes

A. Hart, P. Volf, V. Holan, 2000, Genes and Immunity.

Hereditary motor and sensory neuropathy type I: Clinical and neurographical features of the 17p duplication subtype

A. Hart, B. de Visser, M. de Visser, 1994, Muscle & nerve.

The illusion of the learning phase for lymphatic mapping

A. Hart, P. Tanis, O. Nieweg, 2002, Annals of Surgical Oncology.

Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor control

A. Hart, E. Rutgers, F. van Coevorden, 1994, Cancer.

Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer.

A. Hart, P. Bruning, W. Nooijen, 1989, European journal of cancer & clinical oncology.

Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.

A. Hart, A. Begg, B. Floot, 1988, Cancer research.

Childhood white matter disorders: quantitative MR imaging and spectroscopy.

A. Hart, F. Barkhof, P. Pouwels, 2006, Radiology.

Genetic control of T-cell proliferative response in mice linked to chromosomes 11 and 15

A. Hart, V. Holan, A. Hart, 2007, Immunogenetics.

Genetic dissection of susceptibility to radiation-induced apoptosis of thymocytes and mapping of Rapop1, a novel susceptibility gene.

A. Hart, M. A. van der Valk, P. Demant, 1995, Genomics.

Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response.

A. Hart, J. Schornagel, F. Muggia, 1993, Cancer research.

Prognostic Index for Patients with Parotid Carcinoma External Validation Using the Nationwide 1985–1994 Dutch Head and Neck Oncology Cooperative Group Database

A. Hart, A. Balm, C. Meeuwis, 2003 .

Influence of MHC and Non-MHC Genes on Tumorigenesis and the Use of the Recombinant Congenic Strains as a Novel Tool for the Genetic Analysis of Tumor Susceptibility

A. Hart, M. Valk, L. Oomen, 1990 .

Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma.

A. Hart, L. Strobbe, B. Kroon, 1997 .

Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk.

A. Hart, P. Bruning, J. Bonfrer, 1985, British Journal of Cancer.

Chromogranin A as an Alternative to 5-Hydroxyindoleacetic Acid in the Evaluation of Symptoms during Treatment of Patients with Neuroendocrine Tumors

A. Hart, N. Aaronson, B. Taal, 2008, Neuroendocrinology.

Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma.

A. Hart, D. González González, F. Lammes, 1997, Gynecologic oncology.

Complications of Tenckhoff catheter implantation in patients with multiple previous intraabdominal procedures for ovarian carcinoma.

A. Hart, P. D. de Graaf, W. W. ten Bokkel Huinink, 1988, Gynecologic oncology.

Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment

A. Hart, W. Boogerd, J. J. van der Sande, 1991, Cancer.

Prognostic significance of serum antibodies to human papillomavirus‐16 E4 and E7 peptides in cervical cancer

A. Hart, G. Kenter, J. Trimbos, 1994, Cancer.

Feline mammary tumors: a case-control study of hormonal factors.

A. Hart, W. Misdorp, A. Romijn, 1991, Anticancer research.

[Hodgkin's disease: the effect of age on prognosis].

A. Hart, F. E. van Leeuwen, R. Somers, 1988, Nederlands tijdschrift voor geneeskunde.

Separation of multiple genes controlling the T-cell proliferative response to IL-2 and anti-CD3 using recombinant congenic strains

A. Hart, A. Zajícová, V. Holan, 1995, Immunogenetics.

Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy

A. Hart, F. Zoetmulder, J. Bonfrer, 2002, Annals of Surgical Oncology.

Pseudomyxoma peritonei: a review of 62 cases.

M. J. van de Vijver, A. Hart, F. Zoetmulder, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor.

A. Hart, H. Peterse, F. V. van Leeuwen, 1992, Cancer research.

Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience.

A. Hart, L. Moonen, S. Horenblas, 2005, European urology.

Primary radiotherapy of breast cancer: treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsy.

A. Hart, H. Bartelink, E. Rutgers, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Primary advanced radiotherapy of breast cancer: Treatment results in locally breast cancer and in operable patients selected by positive axillary apex biopsy

A. Hart, H. Bartelink, G. Tienhoven, 1992 .

SPLENECTOMY IN HODGKIN'S DISEASE AND SECOND LEUKAEMIAS

A. Hart, F. Leeuwen, R. Somers, 1987, The Lancet.

Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.

A. Hart, W. Dreschler, J. Schornagel, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of analysis-of-variance-based methods to quantify the random variations of observers in medical imaging measurements: guidelines to the investigator.

A. Hart, K. Gilhuijs, W. Zeggelink, 2004, Medical physics.

Reference Values for Automated Cytochemical Differential Count of Leukocytes in Children 0 — 16 Years Old: Comparison with Manually Obtained Counts from Wright-Stained Smears

A. Hart, N. Abeling, A. H. Gennip, 1985, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

41 Parity and age influence hormonal risk factors of breast cancer

A. Hart, P. Bruning, A. Verstraeten, 1983 .

Staging and prognostic factors in carcinoma of the base of the tongue.

A. Hart, F. Hilgers, P. Schouwenburg, 1992, Clinical otolaryngology and allied sciences.

145 The addition of hyperthermia to standard radiotherapy improves both local control and survival in inoperable pelvic tumours: Results of Dutch randomized studies

A. Hart, P. Koper, J. Zee, 1997 .

Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model.

Cornelis, A. Hart, R. de Boer, 1995, Cancer research.

The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach.

A. Hart, P. Heerde, B. Taal, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome.

A. Hart, A. Hart, P. Demant, 2001, Journal of the National Cancer Institute.

Short Communication Postoperative radiotherapy for rectal and rectosigmoid dose on local control cancer: the impact of total

A. Hart, J. Lebesque, B. Aleman, 1992 .

Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors

A. Hart, A. Twijnstra, B. D. Visser, 1989, Journal of Neuro-Oncology.

The Baxα:Bcl‐2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia

A. Hart, G. Salomons, H. Brady, 1997, International journal of cancer.

Outcome of patients with primary central nervous system lymphoma treated outside clinical trials.

A. Hart, M. Kersten, D. de Jong, 2014, Netherlands Journal of Medicine.

A comparison in cosmetic outcome between per-operative interstitial breast implants and delayed interstitial breast implants after external beam radiotherapy.

A. Hart, J. Peterse, E. Rutgers, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients.

A. Hart, J. Haanen, O. Nieweg, 2005, European journal of cancer.

Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer.

A. Hart, H. Bartelink, A. Begg, 1998, International journal of radiation biology.

Cervical lymph-node metastasis from cutaneous melanoma of the head and neck: a search for prognostic factors.

A. Hart, W. Mooi, A. Balm, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Quantification of patient to patient variation of skin erythema developing as a response to radiotherapy.

A. Hart, J. Lebesque, A. Begg, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Disease-specific survival and locoregional control in tonsillar carcinoma.

A. Hart, P. Levendag, F. Hilgers, 1996, Clinical otolaryngology and allied sciences.

Radiotherapy of tonsillar and base of the tongue carcinoma. Prediction of local control.

A. Hart, J. Lebesque, F. Hilgers, 1993, European journal of cancer. Part B, Oral oncology.

Studies on lung tumours. V. Susceptibility of mice to dimethylnitrosamine‐induced tumour formation in relation to H‐2 haplotype

A. Hart, M. Valk, L. Oomen, 1981, International journal of cancer.

The recombinant congenic strains—a novel genetic tool applied to the study of colon tumor development in the mouse

A. Hart, M. Valk, P. Demant, 2004, Mammalian Genome.

Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma.

A. Hart, P. Baas, H. Schouwink, 1999, Lung cancer.

Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma

A. Hart, J. Mcvie, B. W. Ongerboer de Visser, 1983, Neurology.

Molecular markers of breast cancer metastasis

A. Hart, S. Rodenhuis, B. Weigelt, 2005 .

The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.

A. Hart, M. J. van den Bent, J. Heimans, 2004, European journal of cancer.

Prognostic index for patients with parotid carcinoma

Orlando Guntinas-Lichius, Joseph Schoenaers, Pierre Delaere, 2009, Cancer.

Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors

A. Hart, F. Hilgers, A. Balm, 1999, Cancer.

Gene interaction and single gene effects in colon tumour susceptibility in mice

A. Hart, M. Valk, P. Demant, 1996, Nature Genetics.

Recombinant congenic strains — A new tool for analyzing genetic traits determined by more than one gene

A. Hart, A. Hart, P. Demant, 2004, Immunogenetics.

Radio-immuno assay of lactoferrin in blood plasma of breast cancer patients, lactating and normal women; prevention of false high levels caused by leakage from neutrophile leucocytes in vitro.

A. Hart, P. Rümke, H. G. Kwa, 1971, Folia medica Neerlandica.

Association of C‐MYC amplification with progression from the in situ to the invasive stage in C‐MYC‐amplified breast carcinomas

M. J. van de Vijver, A. Hart, J. Peterse, 2003, The Journal of pathology.

Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.

A. Hart, P. Kristel, F. Hilgers, 1997, Archives of otolaryngology--head & neck surgery.

The impact of treatment time and smoking on local control and complications in T1 glottic cancer.

A. Hart, H. Bartelink, F. Hilgers, 1998, International journal of radiation oncology, biology, physics.

Expression profiling predicts outcome in breast cancer

Yudong D. He, René Bernards, Laura J van 't Veer, 2002, Breast Cancer Research.

Some prognostic and epidemiologic factors in canine osteosarcoma.

A. Hart, W. Misdorp, 1979, Journal of the National Cancer Institute.

Identification and biopsy of the sentinel lymph node in breast cancer.

A. Hart, E. Rutgers, J. V. Dongen, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prediction of poor outcome within the first 3 days of postanoxic coma

A. Hart, R. D. de Haan, M. Verbeek, 2006, Neurology.

Prognostic factors in canine mammary cancer.

A. Hart, W. Misdorp, 1976, Journal of the National Cancer Institute.

Canine mammary cancer. II. Therapy and causes of death.

A. Hart, W. Misdorp, 1979, The Journal of small animal practice.

Carcinoma of the uterine cervix stage I and IIA: results of surgical treatment: complications, recurrence and survival.

A. Hart, J. Delemarre, A. Heintz, 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Late cardiotoxicity after treatment for Hodgkin lymphoma.

A. Hart, H. Bartelink, M. D. De Bruin, 2007, Blood.

Thallium-201-chloride scintigraphy in staging and monitoring radiotherapy response in follicular lymphoma patients.

A. Hart, H. Bartelink, D. de Jong, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Predicting a local recurrence after breast-conserving therapy by gene expression profiling

Howard Y. Chang, P. Brown, M. J. van de Vijver, 2006, Breast Cancer Research.

Risk factors in breast-conservation therapy.

A. Hart, H. Bartelink, H. Peterse, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Malignant histiocytosis and related tumors. A clinicopathologic study of 42 cases using cytological, histochemical and ultrastructural parameters

A. Hart, P. van Heerde, T. Vroom, 1984, Hematological oncology.

Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis

A. Hart, P. Volf, E. Nohýnková, 2002, Immunogenetics.

Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.

A. Hart, F. V. van Leeuwen, B. Taal, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.

A. Hart, H. Bartelink, F. Ong, 2001, International journal of radiation oncology, biology, physics.

Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors.

Marcel J T Reinders, Lodewyk F A Wessels, Tibor van Welsem, 2002, Cancer research.

A protocol for building and evaluating predictors of disease state based on microarray data

Cor J. Veenman, Marcel J. T. Reinders, Lodewyk F. A. Wessels, 2005, Bioinform..

The prognostic significance of the axillary apex biopsy in clinically operable breast cancer.

A. Hart, H. Bartelink, E. Rutgers, 1995, European journal of cancer.

Influence of mouse major histocompatibility complex (H-2) on N-ethyl-N-nitrosourea-induced tumor formation in various organs.

A. Hart, A. Hart, M. A. van der Valk, 1988, Cancer research.

Prognostic significance of CEA in breast cancer: a statistical study.

A. Hart, J. Persijn, F. Cleton, 1981, European journal of cancer & clinical oncology.

Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence.

A. Hart, H. Bartelink, H. Peterse, 1995, European journal of cancer.

Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours.

A. Hart, A. Twijnstra, B. W. Ongerboer de Visser, 1987, Journal of neurology, neurosurgery, and psychiatry.

Pattern of white matter abnormalities at MR imaging: use of polymerase chain reaction testing of Guthrie cards to link pattern with congenital cytomegalovirus infection.

A. Hart, F. Barkhof, J. Loeber, 2004, Radiology.

Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach.

A. Hart, J. Valk, M. S. van der Knaap, 1999, Radiology.

Breast cancer: a study into the value of a historical group as comparative material for new methods of treatment.

A. Hart, J. Peterse, M. Hooning, 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Intratumoral BCG and Corynebacterium parvum therapy of canine mammary tumours before radical mastectomy

A. Hart, J. Salomon, W. Misdorp, 2004, Cancer Immunology, Immunotherapy.

Persistence and accumulation of (potential) single strand breaks in liver DNA of rats treated with diethylnitrosamine or dimethylnitrosamine: correlation with hepatocarcinogenicity.

A. Hart, B. Floot, L. den Engelse, 1979, Chemico-biological interactions.

Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up.

M. J. van de Vijver, A. Hart, H. Bartelink, 2008, International journal of radiation oncology, biology, physics.

Carcinoma of the pyriform sinus: a retrospective analysis of treatment results over a 20-year period.

A. Hart, F. Hilgers, A. Balm, 1995, Clinical otolaryngology and allied sciences.

PROGNOSTICC VALUE OF THE SERUM TUMOUR MARKERSS CYFRA21-1 AND TISSUE POLYPEPTIDE ANTIGENN IN MALIGNANT MESOTHELIOMA

A. Hart, H. Schouwink, '. CatharinaMKorse, 2007 .

Positive Iliac and Obturator Nodes in Melanoma: Survival and Prognostic Factors

A. Hart, L. Strobbe, O. Nieweg, 1999, Annals of Surgical Oncology.

The Value of Cloquet’s Node in Predicting Melanoma Nodal Metastases in the Pelvic Lymph Node Basin

A. Hart, J. Peterse, T. Wobbes, 2001, Annals of Surgical Oncology.

Functional MRI of visual cortex in sedated 18 month‐old infants with or without periventricular leukomalacia

A. Hart, S. Rombouts, J. Valk, 2001, Developmental medicine and child neurology.

Canine mammary cancer. II. Therapy and causes of death.

A. Hart, W. Misdorp, Hart Aa, 1979, The Journal of small animal practice.

The psychological impact of annual chest X-ray follow-up in head and neck cancer

A. Hart, F. Hilgers, N. van Zandwijk, 2006, Acta oto-laryngologica.

The influence of age on treatment choice and survival of elderly breast cancer patients in south-eastern Netherlands: a population-based study.

A. Hart, J. Coebergh, F. Leeuwen, 1992, European journal of cancer.

Differences in estrogen receptor alpha variant messenger RNAs between normal human breast tissue and primary breast carcinomas.

A. Hart, M. van Dijk, L. J. van ’t Veer, 2000, Cancer research.

Advances in Brief Differences in Estrogen Receptor a Variant Messenger RNAs between Normal Human Breast Tissue and Primary Breast Carcinomas 1

A. Hart, L. J. Veer, M. Dijk, 2000 .

The correlation of mammographic-and histologic patterns of breast cancers in BRCA1 gene mutation carriers, compared to age-matched sporadic controls

A. Hart, J. Peterse, S. Muller, 2006, European Radiology.

Different genetic susceptibility to aberrant crypts and colon adenomas in mice.

A. Hart, M. A. van der Valk, P. Demant, 1996, Cancer research.

Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.

A. Hart, A. V. van Geel, A. Eggermont, 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion.

A. Hart, A. Eggermont, A. V. van Geel, 1994, Journal of the American College of Surgeons.

Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.

A. Hart, A. Eggermont, A. V. van Geel, 1994, Surgery.

Reflections on Takahama Jr. et al's “Comparison of two prognostic scores for patients with parotid carcinoma”

A. Hart, V. Vander Poorten, A. Balm, 2009, Head and Neck.

Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or both.

A. Hart, B. Kroon, P. Rümke, 1988, Surgery, gynecology & obstetrics.

Long term survival of thoracoscopic metastasectomy vs metastasectomy by thoracotomy in patients with a solitary pulmonary lesion.

A. Hart, E. Rutgers, P. Baas, 2002, European Journal of Surgical Oncology.

Outcome of thoracoscopic pulmonary metastasectomy evaluated by confirmatory thoracotomy.

A. Hart, E. Rutgers, P. Baas, 2001, The Annals of thoracic surgery.

Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach.

A. Hart, F. C. den Hartog Jager, B. Taal, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Resection of Pulmonary Metastases - Results, Prognostic Factors, Reappraisal of Selection Criteria

A. Hart, N. van Zandwijk, N. Zandwijk, 1986, The Thoracic and cardiovascular surgeon.

Value of resection of pulmonary metastases in head and neck cancer patients

A. Hart, F. Hilgers, N. van Zandwijk, 1996, Head & neck.

Survival of adult patients with head and neck soft tissue sarcomas.

A. Hart, F. Hilgers, F. Coevorden, 1996, Clinical otolaryngology and allied sciences.

Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2.

A. Hart, E. Hooijberg, J. Sein, 1995, Cancer research.

IL-2-induced proliferative response is controlled by loci Cinda1 and Cinda2 on mouse chromosomes 11 and 12: a distinct control of the response induced by different IL-2 concentrations.

A. Hart, V. Holan, M. Lipoldová, 1997, Genomics.

PRAME expression and clinical outcome of breast cancer

A. Hart, A. Glas, R. Bernards, 2008, British Journal of Cancer.

Scc-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24, Pgp-1) on chromosome 2.

A. Hart, P. Demant, M. Snoek, 1992, Oncogene.

Different Genetic Control of Cutaneous and Visceral Disease after Leishmania major Infection in Mice

A. Hart, M. Lipoldová, P. Demant, 2003, Infection and Immunity.

The course of parental expressed emotion and psychotic episodes after family intervention in recent-onset schizophrenia. A longitudinal study

A. Hart, A. Schene, D. Linszen, 2002, Schizophrenia Research.

Dose and volume effects on fibrosis after breast conservation therapy.

A. Hart, H. Bartelink, J. Lebesque, 1994, International journal of radiation oncology, biology, physics.

Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy

A. Hart, J. Peterse, E. Rutgers, 1999, Cancer.

Non-Hodgkin's lymphomata: clinical features in relation to histology.

A. Hart, F. Cleton, R. Somers, 1975, The British journal of cancer. Supplement.

Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation.

Marcel van Herk, Johan Bussink, Isabelle Fitton, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS

A. Hart, I. Fentiman, E. Rutgers, 2002, British Journal of Cancer.

Apoptosis susceptibility genes on mouse chromosome 9 (Rapop2) and chromosome 3 (Rapop3).

A. Hart, P. Demant, N. Mori, 1995, Genomics.

A prospective, randomised and blinded comparison of first shock success of monophasic and biphasic waveforms in out-of-hospital cardiac arrest.

A. Hart, R. Koster, A. V. van Alem, 2003, Resuscitation.

Surgical intervention for complications caused by late radiation damage of the small bowel: a retrospective analysis.

A. Hart, F. Zoetmulder, B. Taal, 1993, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.

J C Horiot, A. Hart, H. Bartelink, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Glucocorticoid hormone effect on transplacental carcinogenesis and lung differentiation: influence of histocompatibility-2 complex.

A. Hart, M. A. van der Valk, L. Oomen, 1989, Journal of the National Cancer Institute.

In vitro differentiation characteristics of human skin fibroblasts: correlations with radiotherapy-induced breast fibrosis in patients.

A. Hart, H. Bartelink, A. Begg, 2000, International journal of radiation biology.

Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: A 10-year single-institute experience

A. Hart, E. Rutgers, F. Coevorden, 2005, Journal of Gastrointestinal Surgery.

Advances in Brief Differences in Breast Cancer Risk Factors to neu ( c-erbB2 ) Protein Overexpression of the Breast Tumor 1

A. Hart, H. Peterse, F. Leeuwen, 2006 .

Accuracy of internal mammary lymph node localization using lymphoscintigraphy, sonography and CT.

A. E. Saarnak, A. Hart, L. S. Schultze Kool, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer.

A. Hart, G. Kenter, M. Gallee, 1994, Gynecologic oncology.

Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment.

A. Hart, H. Bartelink, L. Moonen, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Diffuse Myogenin Expression by Immunohistochemistry is an Independent Marker of Poor Survival in Pediatric Rhabdomyosarcoma: A Tissue Microarray Study of 71 Primary Tumors Including Correlation With Molecular Phenotype

Robert J. Marinelli, M. van de Rijn, A. Hart, 2008, The American journal of surgical pathology.

Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.

A. Hart, J. Peterse, H. Bartelink, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control.

A. Hart, H. Bartelink, L. Moonen, 1998, International journal of radiation oncology, biology, physics.

Primary axillary radiotherapy as axillary treatment in breast‐conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes

A. Hart, J. Peterse, F. Hoebers, 2000, Cancer.

Prognostic Significance of CEA in Colorectal Cancer: A Statistical Study. Clinical evaluation of carcino-embryonic antigen, V

A. Hart, J. Persijn, 1981, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Stage of breast cancers found during the surveillance of women with a familial or hereditary risk.

A. Hart, E. Rutgers, S. Muller, 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Do Mucin‐Secreting Squamous Cell Carcinomas of the Uterine Cervix Metastasize More Frequently To Pelvic Lymph Nodes? A Case‐Control Study

A. Hart, F. Lammes, R. Samlal, 1998, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[Nasopharyngeal carcinoma: epidemiology and treatment outcome].

A. Hart, F. Hilgers, A. Balm, 1997, Nederlandsch tijdschrift voor geneeskunde.

Dose-volume correlation in radiation-related late small-bowel complications: a clinical study.

R W de Boer, A. Hart, H. Bartelink, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Spread according to histology in non-Hodgkin's lymphomata.

A. Hart, F. Cleton, R. Somers, 1975, The British journal of cancer. Supplement.

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

M. Marton, S. Friend, M. J. van de Vijver, 2002 .

A gene-expression signature as a predictor of survival in breast cancer.

Van, M. Marton, S. Friend, 2002, The New England journal of medicine.

Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.

A. Hart, W. Dreschler, J. Schornagel, 2007, International journal of radiation oncology, biology, physics.